SCHEMBL6174755

SCHEMBL6174755

CNC(=O)C(c1ccncc1-c1ccc(OC)cc1)N1C(=O)N(c2ccc(OC(F)(F)F)cc2)C(=O)C1(C)C

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 1/20 0.39
DGAT2 Q96PD7 3/20 0.38
SLC22A12 Q96S37 2/20 0.36
ABL1 P00519 3/20 0.36
CACNA1B Q00975 1/20 0.35
CHRNA7 P36544 1/20 0.35
VNN1 O95497 1/20 0.35
IGF1R P08069 1/20 0.34
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
GSK3A P49840 1/20 0.33
GSK3B P49841 1/20 0.33
P2RY1 P47900 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175120 0.90 IGF1R (0.45) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173204 0.84 CACNA1B (0.37) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6177675 0.81 SCN10A (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL2943931 0.75 IGF1R (0.46) CYP3A4SLC22A12IGF1R
SCHEMBL6174506 0.74 CYP3A4 (0.43) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL2938143 0.70 IGF1R (0.47) IGF1R
SCHEMBL2933138 0.69 GCGR (0.43) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL2938618 0.69 MCHR1 (0.49) CYP3A4SLC22A12
SCHEMBL2940974 0.69 IGF1R (0.48) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL2939757 0.69 IGF1R (0.46) CYP3A4IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed